Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US4831117

Title:Monoclonal antibody specific for human B-cells
Inventors:Uckun, Fatih M.; Minneapolis, MN, USA
Summary:This invention introduces properties of the B-lineage restricted IgG monoclonal antibody, and therapeutic uses thereof. Described herein is a hybridoma which secretes a B-lineage restricted monoclonal antibody of isotype IgG, having all the identifying characteristics of the hybrid cell line ATCC HB 8903. Further disclosed is a process by which this hybridoma and associated monoclonal antibody may be utilized to form an immunotoxin for purging autologous grafts for bone marrow transplantation. Specific therapeutic applications are included for the treatment of lymphoblastic leukemia.
Abstract:
US Patent Website:Click Here for Full Text of Patent
Title Number:US4831117
Application Number:US1986000816141
Date Filed:03/01/1986
Date Published:16/05/1989
Assignee:None


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021